April 09.-10. 2019
Congress Centrum Würzburg
Würzburg, Germany
Thomas Schirrmann will attend the Deutsche Biotechnologie Tage / German Biotech Days in Würzburg. This year the focus is i. a. on:
> Risks & Chances in Science
> Experiences with Gene Therapeutics – From Development to Approval
> One Year thereafter – Status quo of the government´s progress to move forward Biotech in Germany
People attending from YUMAB:
Thomas Schirrmann, PhD
CEO & Founder
